SEC Form 4 · accession 0001209191-18-003689
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Andrew Sherman
Officer — EVP, GEN. COUN. & SECRTY
Period of report
Jan 12, 2018
Accepted (ET)
Jan 16, 2018 · 6:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jan 12, 2018 | M | 10,000 | $28.24 | A | 59,120 | D | |
| Class A Common StockF1 | Jan 12, 2018 | S | 10,000 | $65.00 | D | 49,120 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $28.24 | Jan 12, 2018 | M | 10,000 | D | — | Dec 15, 2021 | Class A Common Stock | 10,000 | 41,219 | D |
Explanation of responses
- F1Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest.
- F2This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
Remarks
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.